2015-2019 Alternative Scenarios of the Future In Vitro Diagnostics Industry: Business-as-Usual, Economic Austerity, Technological Breakthroughs

Date: September 8, 2015
Pages: 255
Price:
US$ 14,500.00
Publisher: VPGMarketResearch.com
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: TD9CB283714EN
Leaflet:

Download PDF Leaflet

2015-2019 Alternative Scenarios of the Future In Vitro Diagnostics Industry: Business-as-Usual, Economic Austerity, Technological Breakthroughs
This new report is designed to help executives develop effective contingency plans that best accommodate uncertainties ahead. The study objectives include:
  • To identify and evaluate emerging markets and technologies that may present unexpected threats or offer opportunities.
  • To identify key strategic decisions that will have to be made in the future.
  • To enhance corporate ability to develop realistic contingency plans.
  • To prepare executives to accommodate radically different operating climates and reduce surprises.
  • To challenge accepted perceptions of the future diagnostics market.
This report is an invaluable strategic planning resource for corporate, marketing and R&D executives. The strategic issues explored in the report include:
  • How will the future reimbursement changes affect individual market segments?
  • Will the industry consolidate, decentralize, or undergo a bimodal transformation?
  • What will be the impact on purchasing influences, marketing strategies, joint ventures, mergers, licensing, import and export?
  • How will the future technological advances affect the major market segment?
  • Which companies will enter the market and which will not survive?
These and other key issues facing the decision-makers are explored in this thought-provoking and multi-faceted portrait of the three possible futures and their strategic implication. We would be glad to answer any questions you might have regarding this informative, comprehensive and insightful market research and technology assessment report, and look forward to your subscription.

Contains 255 pages and 32 tables
I. INTRODUCTION

II. AIDS/HIV WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW


A. Background
B. Diagnostic Tests: HIV-1/2, HIV Ag, NAT, Western Blot
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies

III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES

IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES

V. ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES

VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES

VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES

VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES

IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES

X. ALTERNATIVE MARKET PENETRATION STRATEGIES


A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XII. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe
Hologic
ID Biomedical
Innogenetics/Solvay
Ortho-Clinical Diagnostics/J&J
Kreatech
Life Technologies
Lonza
Nanogen/Elitech
Novartis
PerkinElmer
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wako

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests
France: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
France: HIV Ag Test Volume and Sales Forecasts By Market Segment
France: HIV NAT Blood Screening Test Volume and Diagnostics Sales
France: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
France: AIDS Diagnostics Market by Major Supplier
France: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Germany: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
Germany: HIV Ag Test Volume and Sales Forecasts By Market Segment
Germany: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Germany: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
Germany: AIDS Diagnostics Market by Major Supplier
Germany: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Italy: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
Italy: HIV Ag Test Volume and Sales Forecasts By Market Segment
Italy: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Italy: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
Italy: AIDS Diagnostics Market by Major Supplier
Italy: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Japan: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
Japan HIV Ag Test Volume and Sales Forecasts By Market Segment
Japan: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Japan: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
Japan: AIDS Diagnostics Market by Major Supplier
Japan: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Spain: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
Spain: HIV Ag Test Volume and Sales Forecasts By Market Segment
Spain: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Spain: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
Spain: AIDS Diagnostics Market by Major Supplier
Spain: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
UK: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
UK: HIV Ag Test Volume and Sales Forecasts By Market Segment
UK: HIV NAT Blood Screening Test Volume and Diagnostics Sales
UK: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
UK: AIDS Diagnostics Market by Major Supplier
UK: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
USA: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
USA: HIV Ag Test Volume and Sales Forecasts By Market Segment
USA: HIV NAT Blood Screening Test Volume and Diagnostics Sales
USA: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
USA: AIDS Diagnostics Market by Major Supplier
USA: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Skip to top


Ask Your Question

2015-2019 Alternative Scenarios of the Future In Vitro Diagnostics Industry: Business-as-Usual, Economic Austerity, Technological Breakthroughs
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: